<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.26039.020</object-id><label>Table 1.</label><caption><title>List of primary antibodies used in this study for immunolabeling.</title><p>GFP, Green Fluorescent Protein; Ki67, Marker Of Proliferation Ki-67; MyoD1, Myogenic Differentiation 1; Pax7, Paired Box 7; Phospho-Histone H3 (Ser10), for detection of Histone H3 phosphorylated at serine 10; and Sox17, SRY-Box 17.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Genes</th><th>Sequences</th></tr></thead><tbody><tr><td><italic>Pax7</italic></td><td>5&#8217; &#8211; AGGCCTTCGAGAGGACCCAC &#8211; 3&#8217; <break/>5&#8217; &#8211; CTGAACCAGACCTGGACGCG &#8211; 3&#8217;</td></tr><tr><td><italic>Myf5</italic></td><td>5&#8217; &#8211; TGAGGGAACAGGTGGAGAAC &#8211; 3&#8217; <break/>5&#8217; &#8211; AGCTGGACACGGAGCTTTTA &#8211; 3&#8217;</td></tr><tr><td><italic>Myod</italic></td><td>5&#8217; &#8211; GGCTACGACACCGCCTACTA &#8211; 3&#8217; <break/>5&#8217; &#8211; GAGATGCGCTCCACTATGCT &#8211; 3&#8217;</td></tr><tr><td><italic>Myog</italic></td><td>5&#8217; &#8211; AGTGAATGCAACTCCCACAG &#8211; 3&#8217; <break/>5&#8217; &#8211; ACGATGGACGTAAGGGAGTG &#8211; 3&#8217;</td></tr><tr><td><italic>Myh1</italic></td><td>5&#8217; &#8211; CCAGGAGGCCCCACCCC &#8211; 3&#8217; <break/>5&#8217; &#8211; CACAGTCCTCCCGGCCCC &#8211; 3&#8217;</td></tr><tr><td><italic>Ki67</italic></td><td>5&#8217; &#8211; CCTGTGAGGCTGAGACATGG &#8211; 3&#8217; <break/>5&#8217; &#8211; TCTTGAGGCTCGCCTTGATG &#8211; 3&#8217;</td></tr><tr><td><italic>Sox7</italic></td><td>5&#8217; &#8211; CTTCAGGGGACAAGAGTTCG &#8211; 3&#8217; <break/>5&#8217; &#8211; GGGTCTCTTCTGGGACAGTG &#8211; 3&#8217;</td></tr><tr><td><italic>Sox17</italic></td><td>5&#8217; &#8211; GCCAAAGACGAACGCAAGCGGT &#8211; 3&#8217; <break/>5&#8217; &#8211; TCATGCGCTTCACCTGCTTG &#8211; 3&#8217;</td></tr><tr><td><italic>Sox18</italic></td><td>5&#8217; &#8211; AACAAAATCCGGATCTGCAC &#8211; 3&#8217; <break/>5&#8217; &#8211; CGGTACTTGTAGTTGGGATGG &#8211; 3&#8217;</td></tr><tr><td><italic>Ccnd1</italic></td><td>5&#8217; &#8211; TTCCTCTCCTGCTACCGCAC &#8211; 3&#8217; <break/>5&#8217; &#8211; GACCAGCCTCTTCCTCCACTTC &#8211; 3&#8217;</td></tr><tr><td><italic>Jun</italic></td><td>5&#8217; &#8211; TCCCCTATCGACATGGAGTC &#8211; 3&#8217; <break/>5&#8217; &#8211; TTTTGCGCTTTCAAGGTTTT &#8211; 3&#8217;</td></tr><tr><td><italic>c-myc</italic></td><td>5&#8217; &#8211; GATTCCACGGCCTTCTCTCC &#8211; 3&#8217; <break/>5&#8217; &#8211; GCCTCTTCTCCACAGACACC &#8211; 3&#8217;</td></tr><tr><td><italic>Axin2</italic></td><td>5&#8217; &#8211; AAGAGAAGCGACCCAGTCAA &#8211; 3&#8217; <break/>5&#8217; &#8211; CTGCGATGCATCTCTCTCTG &#8211; 3&#8217;</td></tr><tr><td><italic>Ppard</italic></td><td>5&#8217; &#8211; ATTCCTCCCCTTCCTCCCTG &#8211; 3&#8217; <break/>5&#8217; &#8211; ACAATCCGCATGAAGCTCGA &#8211; 3&#8217;</td></tr><tr><td><italic>Hprt1</italic></td><td>5&#8217; &#8211; AGGGCATATCCAACAACAAACTT &#8211; 3&#8217; <break/>5&#8217; &#8211; GTTAAGCAGTACAGCCCCAAA &#8211; 3&#8217;</td></tr><tr><td><italic>TBP</italic></td><td>5&#8217; &#8211; ATCCCAAGCGATTTGCTG &#8211; 3&#8217; <break/>5&#8217; &#8211; CCTGTGCACACCATTTTTCC &#8211; 3&#8217;</td></tr></tbody></table></table-wrap>